Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized Medicine.

World Med Health Policy. 2015 Mar;7(1):3-27. Gibson S, Raziee HR, Lemmens T. Abstract Pharmaceutical research and development is increasingly focused on niche markets, most notably treatments for rare diseases and “personalized” medicine. Drawing on the results of a qualitative study of 34 key Canadian stakeholders (including drug regulators, funders, scientists, policy experts, pharmaceutical industry representatives,(…)